Long-term reported outcomes of transoral incisionless fundoplication: an 8-year cohort study
- 27 August 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Surgical Endoscopy
- Vol. 33 (4), 1304-1309
- https://doi.org/10.1007/s00464-018-6403-x
Abstract
Background Transoral incisionless fundoplication (TIF) offers an endoscopic approach to the treatment of gastroesophageal reflux disease (GERD). Controlled trials have demonstrated the short-term efficacy of this procedure, but long-term follow-up studies are lacking. The objective of this study was to evaluate the long-term impact of TIF on disease-specific quality of life and antisecretory medication use. Methods We performed retrospective cohort study of all patients undergoing TIF between 2007 and 2014 in a large academic medical center. Reflux symptoms and quality of life were assessed using the gastroesophageal reflux disease health-related quality of life (GERD-HRQL) questionnaire at baseline, short-term, and long-term follow-up. Results Fifty-seven patients with a median age of 46 (37–59) years and an average BMI of 28.8 ± 4.9 kg/m2 underwent TIF during the study period. Sixty percent of the patients were female, and all were taking a PPI at least daily. At a median follow-up interval of 97 months, twelve patients had undergone subsequent laparoscopic antireflux surgery (LARS). Of those who had not, 23 had complete long-term follow-up data for analysis and were included in the study. Seventy-three percent reported daily acid-reducing medication use, and the median GERD-HRQL score was 10 (6–14) compared to 24 (15–28) at baseline (p < 0.01). Seventy-eight percent of these patients expressed satisfaction or neutral feelings about their GERD management. There were no significant differences in the baseline characteristics of patients who underwent LARS during the study period and those who did not. Conclusions This study demonstrates that TIF can produce durable improvements in disease-specific quality of life in some patients with symptomatic GERD. The majority of patients resumed daily PPI therapy during the study period, but with significantly improved GERD-HRQL scores compared to baseline and increased satisfaction with their medical condition.Keywords
This publication has 18 references indexed in Scilit:
- Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover armSurgical Endoscopy, 2016
- Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: a systematic review with meta-analysisSurgical Endoscopy, 2016
- Transoral incisionless fundoplication for gastro-esophageal reflux disease: Techniques and outcomesWorld Journal of Gastrointestinal Pharmacology and Therapeutics, 2016
- Reoperative Antireflux SurgerySurgical Clinics of North America, 2015
- Update on novel endoscopic therapies to treat gastroesophageal reflux disease: A reviewWorld Journal of Gastrointestinal Endoscopy, 2015
- Long-term cost-effectiveness of medical, endoscopic and surgical management of gastroesophageal reflux diseaseSurgery, 2014
- Refractory gastroesophageal reflux disease.Arquivos de Gastroenterologia, 2012
- Response of Regurgitation to Proton Pump Inhibitor Therapy in Clinical Trials of Gastroesophageal Reflux DiseaseThe American Journal of Gastroenterology, 2011
- Long-term outcome of Nissen fundoplication in non-erosive and erosive gastro-oesophageal reflux diseaseBritish Journal of Surgery, 2010
- Oesophageal and gastric pH profiles in patients with gastro‐oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitorsAlimentary Pharmacology & Therapeutics, 2004